Gerenciamento contemporâneo do HIV: Otimizando o uso dos Regimes de TARV atuais

Fornecido em português, este conjunto de slides para download analisa 3 cenários de casos comuns no Brasil: como selecionar TARV em pacientes recém-diagnosticados com HIV, como selecionar TARV para pacientes recém-diagnosticados com coinfecção por HIV / TB e como modificar TARV em pacientes com supressão estável. Revise os principais dados e diretrizes nacionais que suportam cada escolha.
Beatriz Grinsztejn, MD, PhD
Program Director
person default
Erico Arruda, MD, PhD
person default
Monica Jacques de Moraes, MD, PhD
person default
Estevão Portela Nunes, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 636 KB
Released: November 22, 2019

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

Expert-authored CCO slides on the impact of HIV infection on COVID-19 risk and disease severity and the impact of COVID-19 on access to HIV care

W. David Hardy, MD
Program Director
Monica Gandhi, MD, MPH
Released: September 25, 2020

Multimedia module from Clinical Care Options: HIV experts weigh in on selecting first-line ART and modifying ART for those with virologic suppression

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD W. David Hardy, MD Babafemi Taiwo, MBBS
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 18, 2020 Expired: September 17, 2021

Expert discussion of data from AIDS 2020: Virtual on new and established HIV treatment from Drs Lisa Hightow-Weidman and David Wohl, reported by CCO

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Lisa Hightow-Weidman, MD, MPH David A. Wohl, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 11, 2020 Expired: September 10, 2021

CCO-Kommentar von Dr. José Arribas zu den bei der Konferenz „AIDS 2020: Virtual“ gewonnenen neuen Daten, bei der optimale ART-Strategien für Erstlinien- und Zweitlinien-Therapien bewertet wurden

José R. Arribas, MD Released: September 8, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue